PDCD1 and neoplasm: Using synthetic biology technology, tumor antigen peptides, RNA‐binding proteins, and PD‐1 proteins can be displayed on the surface of OMVs for the development of personalized cancer vaccines and the delivery of mRNA vaccines [138, 139, 140].